Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended, 10% Owner at Better Therapeutics, Inc. (BTTX), bought 1,000 shares at $6.84 ($7K) on 2021-12-02, disclosed to the SEC on 2021-12-06.
Open-market purchase of $7k BTTX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.84 | 500 | $3K | 51.5% |
| 2 | $6.43 | 500 | $3K | 48.5% |
| Total | $6.63 avg | 1,000 | $7K | 100% |
| Filing → |
| BTTX | BUY | 2021-12-17 | $4K | — | Filing → |
| BTTX | BUY | 2021-12-14 | $6K | — | Filing → |